Is Natera Inc (NASDAQ: NTRA) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

NTRA belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Natera Inc is $11.02B. A total of 0.76 million shares were traded on the day, compared to an average of 1.45M shares.

In the most recent transaction, Chapman Steven Leonard sold 83,223 shares of NTRA for 88.96 per share on Mar 15 ’24. After the transaction, the CEO AND PRESIDENT now owns 232,004 company shares. In a previous transaction on Mar 06 ’24, Sheena Jonathan sold 5,000 shares at 88.70 per share. NTRA shares that CO-FOUNDER owns now total 458,585.

Among the insiders who sold shares, Rabinowitz Matthew disposed of 190,000 shares on Mar 05 ’24 at a per-share price of $87.40. This resulted in the EXECUTIVE CHAIRMAN holding 860,036 shares of NTRA after the transaction. In another insider transaction, Chapman Steven Leonard sold 9,326 shares at $88.36 per share on Mar 05 ’24. Company shares held by the CEO AND PRESIDENT now total 246,957.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NTRA has a high of $93.48 and a low of $36.90.

As of this writing, NTRA has an earnings estimate of -$0.71 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of -$0.63 per share and a lower estimate of -$0.78. The company reported an EPS of -$0.95 in the last quarter, which was 1.00% higher than expectations of -$0.96.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NTRA’s latest balance sheet shows that the firm has $914.28M in Cash & Short Term Investments as of fiscal 2021. There were $397.23M in debt and $218.96M in liabilities at the time. Its Book Value Per Share was $6.40, while its Total Shareholder’s Equity was $653.30M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTRA is Buy with a score of 4.73.

Most Popular

Related Posts